Oncotherapeutics

West Hollywood, United States Founded: 1988 • Age: 38 yrs
Preclinical and clinical oncology drug development services are provided.
Request Access

About Oncotherapeutics

Oncotherapeutics is a company based in West Hollywood (United States) founded in 1988.. Oncotherapeutics has raised $8.3 million across 1 funding round from investors including Domain Associates and TVM Capital Life Science. Oncotherapeutics operates in a competitive market with competitors including Helsinn, Aster Insights, CancerVax, Abogen Biosciences and OnCusp, among others.

  • Headquarter West Hollywood, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $8.3 M (USD)

    in 1 rounds

  • Latest Funding Round
    $8.3 M (USD), Series A

    Jun 01, 1993

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    N/A

    (Sep 04, 1995)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Oncotherapeutics

Oncotherapeutics has successfully raised a total of $8.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.3 million completed in June 1993. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $8.3M
  • First Round

    (01 Jun 1993)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 1993 Amount Series A - Oncotherapeutics Valuation Domain Associates
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Oncotherapeutics

Oncotherapeutics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Domain Associates and TVM Capital Life Science. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Life science & tech focused VC firm investing in the US
Founded Year Domain Location
Capital is invested in life science innovations for healthcare transformation.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Oncotherapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Oncotherapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Oncotherapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Oncotherapeutics

Oncotherapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, CancerVax, Abogen Biosciences and OnCusp, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
domain founded_year HQ Location
Contract-based oncology clinical trial services are provided by Aster Insights.
domain founded_year HQ Location
Cancer vaccine research and development is conducted by CancerVax.
domain founded_year HQ Location
mRNA-based therapeutics are developed for cancer and infectious diseases.
domain founded_year HQ Location
CRO offering clinical development services for oncology drugs
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Oncotherapeutics

When was Oncotherapeutics founded?

Oncotherapeutics was founded in 1988 and raised its 1st funding round 5 years after it was founded.

Where is Oncotherapeutics located?

Oncotherapeutics is headquartered in West Hollywood, United States. It is registered at West Hollywood, California, United States.

Who is the current CEO of Oncotherapeutics?

James Berenson is the current CEO of Oncotherapeutics.

Is Oncotherapeutics a funded company?

Oncotherapeutics is a funded company, having raised a total of $8.3M across 1 funding round to date. The company's 1st funding round was a Series A of $8.3M, raised on Jun 01, 1993.

What does Oncotherapeutics do?

Oncotherapeutics was founded in 1988 and is based in West Hollywood, United States. As a contract research organization in the oncology sector, services are extended for drug development across preclinical and phase I-IV clinical trials. Offerings encompass project team management, medical writing, data management and analysis, regulatory submissions, CRFeCRF design, patient recruitment, and protocol development. Operations emphasize timelines for study start-up, enrollment, and completion.

Who are the top competitors of Oncotherapeutics?

Oncotherapeutics's top competitors include Helsinn, CancerVax and OnCusp.

Who are Oncotherapeutics's investors?

Oncotherapeutics has 2 investors. Key investors include Domain Associates, and TVM Capital Life Science.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available